UNIGE document Scientific Article - Review
previous document  unige:27726  next document
add to browser collection
Title

IFNβ and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis

Authors
Published in Communicative & Integrative Biology. 2011, vol. 4, no. 1, p. 112-4
Abstract Imbalance in cytokine homeostasis plays an important part in the pathogenesis of various chronic inflammatory diseases. In multiple sclerosis (MS), the pro-inflammatory cytokine interleukin-1β (IL-1β) is present in the central nervous system, being expressed mainly in infiltrating macrophages and microglial cells. IL-1β activity is inhibited by the secreted form of IL-1 receptor antagonist (sIL-1Ra) whose production is increased in patients' blood and induced in human monocytes by IFNβ and glatiramer acetate (GA)-both immunomodulators displaying similar therapeutic efficacy in MS. Because intracellular pathways are currently considered as potential therapeutic targets, identification of specific kinases used by both immunomodulators might lead to more specific therapeutic targeting. We addressed the question of intracellular pathways used by IFNβ and GA to induce sIL-1Ra in human monocytes in two recent studies. This addendum to these studies aims at discussing common pathways and different elements used by IFNβ and GA to induce sIL-1Ra in human monocytes. This pinpoints PI3Kδ activation as a requirement to induce sIL-1Ra production downstream monocyte stimulation by either IFNβ or GA. However, the immunomodulators differentially use MEK/ERK pathway to induce sIL-1Ra production in human monocytes. Together, our current studies suggest that PI3Kδ and MEK2 might represent new targets in MS therapy.
Identifiers
PMID: 21509198
Full text
Article (Published version) (401 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Inflammation et allergie (874)
Citation
(ISO format)
CARPINTERO, Rakel, BURGER, Danielle. IFNβ and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis. In: Communicative & Integrative Biology, 2011, vol. 4, n° 1, p. 112-4. https://archive-ouverte.unige.ch/unige:27726

181 hits

0 download

Update

Deposited on : 2013-05-08

Export document
Format :
Citation style :